I spoke with the president of American Biotech. Their patent on making the silver is at:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=/netahtml/srchnum.htm&r=1&f=G&l=50&s1=6214299.WKU.&OS=PN/6214299&RS=PN/6214299 It looks basically like the SilverPro method with one electrode submerged, and with stirring. He claims that the CS thus made will not kill spores (as we determined), but that they have some type of secret process that then converts the silver particles to be much more effective, and that after this process that takes hours, it will kill spores without having to germinate them. They add nothing to the CS, it is pure water and silver. Marshall [email protected] wrote: > > > Hello List, > > Clifton Mining (CFTN-OTC) and American Biotech produce a colloidal > silver compound that arrests the effects of malaria. The mosquito-born > fever kills 2.7 million people a year, mostly African children. The > world spends $300 million a year on malaria control and a WHO progress > report on the $700 million Roll Back Malaria campaign conducted over > the past two years has achieved little. UN Secretary General Kofi > Annan is from Ghana, where successful tests have been completed, which > in hospital trials shows that American Biotech and Clifton Mining's > colloidal silver product ASAP arrests the effects of malaria. The two > companies' representative met this week with WHO executives to discuss > the possible use of ASAP via the World Health Organization. Malaria > costs the African economy $12 billion a year. > > Clifton Mining Company (OTC: CFTN) > Alpine, Utah: November 11th, 2002. Clifton Mining Company (OTC: CFTN) > is pleased to announce that American Biotech Labs, a company in which > Clifton owns approximately 30% has finished the approval process with > the U.S. EPA and expects to get full hospital approval in the next few > weeks. > > The Testing > > In the test work for the EPA hospital approval, the ASAP Solution® > had to kill hundreds of thousands of some of the deadliest types of > bacteria found in the United States within minutes, and it proved able > to do so. There were approximately 1600 individual bacterial tests in > just one series alone. American Biotech's product was able to pass all > the tests. > > The Hospital Approval > > American Biotech Labs expects to get the full hospital disinfectant > approval within the next 15-45 days. The approval will open the door > to sell the highly effective, yet non-toxic disinfectant to thousands > of hospitals, clinics, rest homes, and other healthcare facilities > worldwide. Management expects sales of the new disinfectant to > possibly begin as soon as January 2003. Said Keith Moeller, V.P., > "This will be a very important product for the market. Because this > product is non-toxic and yet highly effective at killing even the MRSA > super bacteria, we expect sales to boom worldwide. Unlike other > disinfectants, this product can be used in and around patients to kill > bacteria with no adverse effect. It is so safe that it could be > sprayed right on the skin or even consumed orally with no adverse > consequences." > > Malaria Testing/Drug Approval > > A new human trial specifically testing ASAP's effectiveness on malaria > is under way in Ghana, West Africa. In the first two tests, 19 people > who had been diagnosed with malaria were treated with the ASAP > Solution. All 19 people (mostly children) were reported by the doctors > as being fully recovered within just seven days. The latest malaria > tests should be completed within the next 60 days. With no reported > failures, the human tests have gone so well that the official Food and > Drug Board of Ghana has already approved the ASAP Solution® for drug > registration. Recent West African trials also tested the product as a > treatment for fungal skin infections, vaginal infections, urinary > tract infections, tonsillitis, pharingitis, some sexually transmitted > diseases, conjunctivitis, upper respiratory tract infections, nasal > and sinus problems, etc. In almost every human case tested so far, > full recovery was reached in just 1-7 days. > > http://www.kitco.com/ind/Chapman/nov122002.html > > Michael > > > > > >
